Subsidiary President Andrew Gesek resigns; Petros to integrate his role

Petros Pharmaceuticals, Inc.

Andrew Gesek resigned as President of Timm Medical Technologies effective Feb 28, 2022; no disagreement cited.
Company will not hire a replacement; plans to streamline and integrate operations under current leadership.
Gesek receives $75,000 cash severance (3 months base salary) paid pro rata over three months.
Severance includes 24-month non-compete, non-solicitation, and non-disparagement covenants.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andrew Gesek

President of Timm Medical Technologies, Inc.

PTPI · Petros Pharmaceuticals, Inc.

Effective: 2022-02-28
Filed: March 4, 2022, 6:59 PM ET

On February 28, 2022 (the “Termination Date”), Andrew Gesek resigned from his position as President of Timm Medical Technologies, Inc., a wholly-owned subsidiary of Petros Pharmaceuticals, Inc. (the “Company”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Gesek resigned as President of Timm Medical Technologies, Inc. at Petros Pharmaceuticals, Inc..

Action: resigned
Role: President of Timm Medical Technologies, Inc.

Exact text from the filing

On February 28, 2022 (the “Termination Date”), Andrew Gesek resigned from his position as President of Timm Medical Technologies, Inc., a wholly-owned subsidiary of Petros Pharmaceuticals, Inc. (the “Company”), effective immediately.

View on SEC.gov

Petros Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-030657

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.